• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏格兰睾丸癌发病率和死亡率的变化,特别提及老年非精原细胞瘤性生殖细胞肿瘤患者的治疗结果。

Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours.

作者信息

Hatton M Q, Paul J, Harding M, MacFarlane G, Robertson A G, Kaye S B

机构信息

Beatson Oncology Centre, Western Infirmary, Glasgow.

出版信息

Eur J Cancer. 1995;31A(9):1487-91. doi: 10.1016/0959-8049(95)00298-w.

DOI:10.1016/0959-8049(95)00298-w
PMID:7577077
Abstract

This paper describes the temporal pattern of germ cell testicular cancer in Scotland between 1960 and 1990. The effect of age on the prognosis of patients with non-seminomatous germ cell tumours (NSGCT) has been assessed by studying all patients presenting in the West of Scotland between 1975 and 1989. Between 1960 and 1990, the number of testicular germ cell tumours registered has increased more than 2-fold; mortality rates have declined equally dramatically. Univariate and multivariate analysis of the data obtained on 440 patients with NSGCT showed age was not a prognostic factor influencing survival. 52 were patients over 40 years at presentation; their 5 years survival was 71% compared with 79% in the younger patients (n = 388). This small survival difference is probably explained by the higher proportion of older patients treated before 1980. Treatment for this older group should be approached with the same curative intent as for younger patients and the same expectation of success.

摘要

本文描述了1960年至1990年间苏格兰睾丸生殖细胞癌的时间模式。通过研究1975年至1989年间在苏格兰西部就诊的所有患者,评估了年龄对非精原细胞性生殖细胞肿瘤(NSGCT)患者预后的影响。1960年至1990年间,登记的睾丸生殖细胞肿瘤数量增加了两倍多;死亡率也同样显著下降。对440例NSGCT患者的数据进行单因素和多因素分析显示,年龄不是影响生存的预后因素。52例患者初诊时年龄超过40岁;他们的5年生存率为71%,而年轻患者(n = 388)的5年生存率为79%。这种较小的生存差异可能是由于1980年前接受治疗的老年患者比例较高。对这一年龄较大群体的治疗应与年轻患者一样具有治愈意图,并抱有同样的成功期望。

相似文献

1
Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours.苏格兰睾丸癌发病率和死亡率的变化,特别提及老年非精原细胞瘤性生殖细胞肿瘤患者的治疗结果。
Eur J Cancer. 1995;31A(9):1487-91. doi: 10.1016/0959-8049(95)00298-w.
2
Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.非精原细胞性生殖细胞肿瘤的治疗结果;1981 - 1985年苏格兰西部连续122例病例
Br J Cancer. 1988 Feb;57(2):182-5. doi: 10.1038/bjc.1988.38.
3
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.大体积播散性非精原细胞性生殖细胞肿瘤患者的交替剂量密集化疗。
Br J Cancer. 2002 May 20;86(10):1555-60. doi: 10.1038/sj.bjc.6600272.
4
Changes in testicular cancer in Scotland.
Eur J Cancer Clin Oncol. 1987 Jun;23(6):827-30. doi: 10.1016/0277-5379(87)90286-0.
5
The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.1975 - 1989年苏格兰西部非精原细胞瘤性生殖细胞肿瘤的流行病学
Br J Cancer. 1995 Dec;72(6):1559-62. doi: 10.1038/bjc.1995.548.
6
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.I期睾丸生殖细胞肿瘤的监测:管理方案的结果及成本效益分析
Eur J Cancer. 2000 Oct;36(15):1925-32. doi: 10.1016/s0959-8049(00)00140-4.
7
Germ cell tumours in uncorrected cryptorchid testis at Institute Rotary Cancer Hospital, New Delhi.新德里扶轮癌症医院未矫正隐睾中的生殖细胞肿瘤。
Br J Cancer. 1995 Feb;71(2):380-2. doi: 10.1038/bjc.1995.77.
8
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.原发性睾丸肿瘤中的畸胎瘤会降低初次化疗后腹膜后区域的完全缓解率。关于对伴有畸胎瘤成分的IIb期生殖细胞肿瘤进行原发性腹膜后淋巴结清扫术的理由。
Cancer. 1996 Aug 1;78(3):480-6. doi: 10.1002/(SICI)1097-0142(19960801)78:3<480::AID-CNCR15>3.0.CO;2-V.
9
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.基于顺铂的化疗后进展的恶性非精原细胞瘤患者的预后因素。
Br J Cancer. 1999 Jul;80(9):1392-9. doi: 10.1038/sj.bjc.6690534.
10
Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.苏格兰睾丸生殖细胞肿瘤患者转诊至专科肿瘤中心的模式。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1300-2. doi: 10.1038/bjc.1995.504.

引用本文的文献

1
Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.睾丸生殖细胞肿瘤:首次就诊时临床特征的描述性分析
Urol Int. 2018;100(4):409-419. doi: 10.1159/000488284. Epub 2018 Apr 12.
2
A Review in Management of Testicular Cancer: Single Center Review.睾丸癌管理综述:单中心综述
World J Oncol. 2011 Jun;2(3):94-101. doi: 10.4021/wjon258w. Epub 2011 Jun 8.
3
Current trends of male reproductive health disorders and the changing semen quality.男性生殖健康障碍的当前趋势及精液质量的变化
Int J Prev Med. 2014 Jan;5(1):1-5.
4
Spatial variation and temporal trends of testicular cancer in Great Britain.英国睾丸癌的空间变异与时间趋势。
Br J Cancer. 2001 Jun 1;84(11):1482-7. doi: 10.1054/bjoc.2001.1739.
5
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.顺铂时代转移性非精原细胞瘤性生殖细胞肿瘤的管理进展:单机构经验
Br J Cancer. 1996 Oct;74(8):1280-5. doi: 10.1038/bjc.1996.530.
6
Is the human testis still an organ at risk?人类睾丸仍是一个有风险的器官吗?
BMJ. 1996 Jun 22;312(7046):1557-8. doi: 10.1136/bmj.312.7046.1557.